New radiation therapy with chemo and immunotherapy for oral cavity cancer
Part of Cancer clinical trials.
This trial tests a new way of giving radiation therapy along with chemotherapy and immunotherapy for advanced oral cavity cancer. It aims to improve how well the treatment works while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have oral cavity cancer (such as of the tongue, gum, or cheek) confirmed by biopsy or other test.
- Your cancer is limited to the head and neck area and has not spread to distant organs.
- Your cancer is removable with surgery — you haven't already had surgery that removed it completely.
- You are generally in good health, able to carry on all normal activities, and have good kidney and blood function.
- If you are able to become pregnant, you must have a negative pregnancy test and use highly effective birth control during the study.
- You should not have certain metallic implants or conditions that rule out an MRI, such as a pacemaker or severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two types of radiation therapy combined with an immunotherapy drug called pembrolizumab before surgery for oral cavity cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
This trial tests a new way of giving radiation along with standard chemotherapy and an immunotherapy drug for throat cancer. The goal is to see if this combination can better target the tumor, reduce side effects, and improve outcomes for patients with oropharyngeal cancer.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This trial tests combining radiation therapy with immunotherapy and chemotherapy before surgery for advanced oral or throat cancer. The goal is to see if this approach can shrink the tumor and improve treatment outcomes.
This trial is testing a combination of low-dose radiation, immunotherapy, and chemotherapy for people with advanced oral cancer that hasn't been treated before. The goal is to see if this approach can help control the cancer and possibly improve outcomes.
Hear when a new Oral Cavity Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.